A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors

被引：30
|
作者：
Rani, Sudesh [1 ]
Raheja, Konpal [1 ]
Luxami, Vijay [1 ]
Paul, Kamaldeep [1 ]
机构：
[1] Thapar Inst Engn & Technol, Sch Chem & Biochem, Patiala 147001, Punjab, India
来源：
BIOORGANIC CHEMISTRY | 2021年 / 113卷
关键词：
Non-steroidal aromatase; Structure-activity relationship; Breast cancer; Heterocycles; Medicinal chemistry; BREAST-CANCER; MOLECULAR DOCKING; BIOLOGICAL CHARACTERIZATION; SELECTIVE INHIBITORS; ADJUVANT TREATMENT; ESTROGEN-RECEPTOR; HIGHLY POTENT; DERIVATIVES; TAMOXIFEN; MECHANISM;
D O I：
10.1016/j.bioorg.2021.105017
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Breast cancer, emerging malignancy is common among women due to overexpression of estrogen. Estrogens are biosynthesized from androgens by aromatase, a cytochrome P450 enzyme complex, and play a pivotal role in stimulating cell proliferation. Therefore, deprivation of estrogen by blocking aromatase is considered as the effective way for the inhibition and treatment of breast cancer. In recent years, various non-steroidal heterocyclic functionalities have been extensively developed and studied for their aromatase inhibition activity. This review provides information about the structural-activity relationship of heterocycles (Type II) towards aromatase. This aids the medicinal chemist around the significance of different heterocyclic moieties and helps to design potent aromatase inhibitors.
引用
收藏
页数：27
相关论文
共 50 条
  • [31] Towards a New Generation of Hormone Therapies: Design, Synthesis and Biological Evaluation of Novel 1,2,3-Triazoles as Estrogen-Positive Breast Cancer Therapeutics and Non-Steroidal Aromatase Inhibitors
    Rashdan, Huda R. M.
    Abdelrahman, Mohamad T.
    De Luca, Anna Chiara
    Mangini, Maria
    PHARMACEUTICALS, 2024, 17 (01)
  • [32] Molecular Modelling, Design, Synthesis and Biochemical Evaluation of a Range of Non-Steroidal Thiosemicarbazone-Based Inhibitors of Estrone Sulfatase (ES) - A Potential Insight into the Action of a Range of Allosteric Inhibitors of ES
    Kumar, Amit
    Singh, Sukriti
    Bhamare, Balkrishna
    Shah, Kruti
    Shah, Pallav S.
    Ahmed, Sabbir
    LETTERS IN DRUG DESIGN & DISCOVERY, 2011, 8 (09) : 889 - 896
  • [33] Exemestane in metastatic breast cancer: Effective therapy after third-generation non-steroidal aromatase inhibitor failure
    Steele, N.
    Zekri, J.
    Coleman, R.
    Leonard, R.
    Dunn, K.
    Bowman, A.
    Manifold, I.
    Kunkler, I.
    Purohit, I.
    Cameron, D.
    BREAST, 2006, 15 (03): : 430 - 436
  • [34] Compounds Containing Azole Scaffolds as Cyclooxygenase Inhibitors: A Review
    Ragab, Hanan M. A.
    Bekhit, Adnan A.
    Rostom, Sherif A. F.
    Bekhit, Alaa El-Din A.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (30) : 3569 - 3581
  • [35] Topical non-steroidal agents for the prevention of radiation dermatitis: a systematic review and meta-analysis
    Fatima, Sakeena
    Hirakawa, Satoshi
    Marta, Gustavo Nader
    Caini, Saverio
    Beveridge, Mara
    Bonomo, Pierluigi
    Chow, Edward
    van den Hurk, Corina
    Ryan Wolf, Julie
    Lam, Henry
    Behroozian, Tara
    SUPPORTIVE CARE IN CANCER, 2023, 31 (04)
  • [36] Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer
    Geisler, J
    King, N
    Dowsett, M
    Ottestad, L
    Lundgren, S
    Walton, P
    Kormeset, PO
    Lonning, PE
    BRITISH JOURNAL OF CANCER, 1996, 74 (08) : 1286 - 1291
  • [37] Aspirin and Other Non-Steroidal Anti-Inflammatory Drugs as Cyclooxygenase Inhibitors: State of the Art, Barriers and Perspectives
    Avram, Speranta
    Duda-Seiman, Daniel M.
    Svab, Istvan
    Mancas, Silvia
    Duda-Seiman, Corina
    Mihailescu, Dan F.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2009, 5 (01) : 1 - 12
  • [38] Monoamine oxidase B inhibitors based on natural privileged scaffolds: A review of systematically structural modification
    Lv, Yangjing
    Zheng, Zhiyuan
    Liu, Renzheng
    Guo, Jianan
    Zhang, Changjun
    Xie, Yuanyuan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 251
  • [39] Combinatorial Effect of Non-Steroidal Anti-inflammatory Drugs and NF-κB Inhibitors in Ovarian Cancer Therapy
    Zerbini, Luiz F.
    Tamura, Rodrigo E.
    Correa, Ricardo G.
    Czibere, Akos
    Cordeiro, Jason
    Bhasin, Manoj
    Simabuco, Fernando M.
    Wang, Yihong
    Gu, Xuesong
    Li, Linglin
    Sarkar, Devanand
    Zhou, Jin-Rong
    Fisher, Paul B.
    Libermann, Towia A.
    PLOS ONE, 2011, 6 (09):
  • [40] Synthesis and in vitro evaluation of diverse heterocyclic diphenolic compounds as inhibitors of DYRK1A
    Zhou, Qingqing
    Reekie, Tristan A.
    Abbassi, Ramzi H.
    Venkata, Dinesh Indurthi
    Font, Josep S.
    Ryan, Renae M.
    Munoz, Lenka
    Kassiou, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (22) : 5852 - 5869
12345